PMA P150013S025

Device
PD-L1 IHC 22C3 pharmDx
Applicant
Agilent Technologies, Inc.
PMA number
P150013
Supplement
S025
Product code
PLS
Decision date
2022-11-03
Generic name
Immunohistochemistry assay, antibody, programmed death-ligand 1
Approval order statement
Approval of the cut section storage recommendation for cervical cancer tissue will be updated, to change the recommended maximum duration of storage at 2-8ºC from 5 months to 2 months.

Current openFDA PMA Record#

Device
PD-L1 IHC 22C3 pharmDx
Applicant
Agilent Technologies, Inc.
PMA number
P150013
Supplement
S025
Product code
PLS
Generic name
Immunohistochemistry assay, antibody, programmed death-ligand 1
Decision date
2022-11-03
Decision code
APPR
Date received
2022-08-08
Supplement type
Real-Time Process
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Approval order statement
Approval of the cut section storage recommendation for cervical cancer tissue will be updated, to change the recommended maximum duration of storage at 2-8ºC from 5 months to 2 months.